Francesco Patalano
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Respiratory and Cough-Related Research, Respiratory Support and Mechanisms, Ophthalmology and Visual Impairment Studies
Most-Cited Works
- → Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD(2016)861 cited
- → Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial(2018)259 cited
- → Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial(2017)165 cited
- → LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis(2017)160 cited
- → LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD(2015)160 cited
- → FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease(2015)120 cited
- → Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD(2018)89 cited
- → Patient-reported outcome measures in presbyopia: a literature review(2020)60 cited
- → Endothelin-1 Induces Increased Fibronectin Expression in Human Bronchial Epithelial Cells(1996)58 cited
- → Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease(2017)55 cited